New clinical trial (phase 3) in metastatic colorectal cancer:
Adding tumor debulking surgery to standard palliative chemotherapy did not significantly improve survival.
Median survival:(382 pts)
• Chemo alone: 27.5 months
• Chemo + surgery: 30 months
👉 Takeaway: Surgery may not add clear survival benefit in patients with multiorgan metastases.
#MedTwitter #Oncology #ColorectalCancer https://jamanetwork.com/journals/jama/fullarticle/2846530 #press


